For the Culture By The Culture
A proposed federal hemp framework is being sold as long overdue clarity for a chaotic market. But beneath the promise of order, the structure reveals rigid caps, unresolved enforcement questions, and a quiet shift of power away from states and smaller producers. We break down what the proposal does, what it avoids, and why the difference matters.
Actor David Krumholtz’s experience with Cannabinoid Hyperemesis Syndrome sparked a backlash that reveals a deeper problem in cannabis culture. This piece examines how rare conditions get weaponized, why defensive reactions backfire, and how patients, veterans, and families are erased when nuance collapses on both sides of the cannabis debate.
Texas regulators are moving to eliminate smokable cannabis without passing a law. After lawmakers failed to ban THC products, state agencies rewrote testing standards and imposed crushing fees that push legal cannabis out of reach. The result is prohibition by process, driven by selective morality, political pressure, and regulatory maneuvering.
Federal officials claim cannabis is moving forward, but Schedule III changes nothing that matters. This investigation breaks down what rescheduling actually does, what it deliberately avoids, and why prohibition logic remains intact. Arrests continue. Markets remain conflicted. Reform language replaces reform action. The system shifts labels while preserving control.
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.
Cannabis rescheduling keeps resurfacing in headlines, then vanishes without action. This feature breaks down how federal officials repeatedly float reform language, let deadlines pass, and leave the law untouched. By tracing the mechanics behind the stall, the piece exposes why delay is intentional, who benefits from it, and why cannabis reform remains trapped in federal limbo.
